| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Accounting Fees | 1,000 | 0 | 0 | 0 |
| Name | Date Acquired | How Acquired | Date Sold | Purchaser Name | Gross Sales Price | Basis | Basis Method | Sales Expenses | Total (net) | Accumulated Depreciation |
|---|---|---|---|---|---|---|---|---|---|---|
| Fidelity DisciplinedEquity | 2013-10 | Donation | 2024-01 | 2,500 | 2,450 | 0 | 50 | 0 | ||
| T ROWE Price Blue Chip Growth | 2013-10 | Donation | 2024-05 | 2,500 | 841 | 0 | 1,659 | 0 | ||
| Exxon Mobil Corp Com | 2010-01 | Donation | 2024-05 | 3,909 | 2,155 | 0 | 1,754 | 0 | ||
| Exxon Mobile Corp Com | 2010-03 | Donation | 2024-05 | 1,185 | 673 | 0 | 512 | 0 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| Fidelity Money Market | 6,936 | 6,936 |
| Fidelity Disciplined | 29,172 | 29,172 |
| T Rowe Price Blue Chip Growth | 13,819 | 13,819 |
| Vanguard Dividend Growth | 21,396 | 21,396 |
| Exxon Mobile | 16,390 | 16,390 |
| Pfizer | 59,613 | 59,613 |
| Walmart | 26,182 | 26,182 |
| Fidelity Capital & Income | 22,414 | 22,414 |
| Invesco Rochester Muni | 34,975 | 34,975 |
| I Shares Core S&P 500 | 10,758 | 10,758 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Legal Fees | 3,128 | 0 | 0 | 0 |
| Description | Beginning of Year - Book Value | End of Year - Book Value | End of Year - Fair Market Value |
|---|---|---|---|
| Unrealized Losses | 87,024 | 75,278 | 75,278 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Taxes | 111 | 0 | 0 | 0 |